NADOXOLOL
UNII SK43HU1689

Substance Identification & Data

This profile provides standardized clinical and technical data for Nadoxolol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SK43HU1689.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 54063-51-3 and the RxNorm Concept ID (RxCUI) 31462. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
SK43HU1689
CAS Registry Number
54063-51-3
RxNorm Concept ID

Detailed Substance Profile

Preferred Name
NADOXOLOL
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C14H16N2O3
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
UPZVYDSBLFNMLK-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
INN ID
3322
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O(c1c2c(ccc1)cccc2)CC(CC(NO)=N)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nadoxolol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NADOXOLOL

Common Names & Synonyms

NADOXOLOL [INN]
NADOXOLOL [MI]
NADOXOLOL [WHO-DD]

Systematic Nomenclature

3-HYDROXY-4-(1-NAPHTHYLOXY)BUTYRAMIDOXIME
BUTANIMIDAMIDE, N,3-DIHYDROXY-4-(1-NAPHTHALENYLOXY)-
N,3-DIHYDROXY-4-(1-NAPHTHALENYLOXY)BUTANIMIDAMIDE

Technical Codes

LL 1530